Patented device
Orgonex’ first product will be an organoid culture bioreactor. The RPMotion’s first generation is created for advanced expansion and differentiation of organoids on a small-scale (5 to 50 mL (5×10⁵ cells)). Its modular design makes it possible to expand up to 32 bioreactors in one incubator, which makes it perfect for academic research or industrial R&D applications.
The RPMotion bioreactor is unique in its kind. No other way of culturing is able to get results like Orgonex’ bioreactor with decreasing labor by 75% and reducing medium costs up to 60%. A patent has already been filed. And we have an exclusive license from Utrecht University for all life sciences cell culture applications.

Unique plug-and-play system
Its multiplex feature allows it to run 4 tubes in parallel, thus enabling simultaneous experiments, devices can be connected through a simple plug-and-play feature, with up to 32 bioreactors fitting into one laboratory incubator. All devices are controlled through an intuitive external LCD screen, which allows the customer to cycle through different programs that fit the needs of their specific organoid type.
.jpg)
For the academic and industrial R&D market
The RPMotion bioreactor is suitable for expansion and differentiation of organoids on a small-scale, which makes it perfect for academic research or industrial R&D applications. Future Market Insights report 2021 mentions that the academic and research institutes segment worldwide is estimated to hold for the largest revenue share of the organoids market of 68.8% ($585M) in 2021 owing to higher adoption of organoids into research studies. The industrial R&D/preclinical segment is represented by 31,2% ($265M).

"We live in an extraordinary time, full of potential."
Kerstin Schneeberger, Co-Founder of Orgonex
Want to know more about our product?
Do not hesitate to send us a message.